FLT1 and hepatocellular carcinoma: For advanced unresectable HCC, the recommended treatments include regorafenib and sorafenib (tyrosine kinase inhibitors (TKIs)) and the vascular endothelial growth factor receptors 1 through 3 (VEGFR1-3) inhibitor, lenvatinib.